title: High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact?
authors.forename: Gerald L
authors.initials: GL
authors.lastname: Andriole
authors.forename: Peter A
authors.initials: PA
authors.lastname: Humphrey
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Serfling
authors.forename: Robert L
authors.initials: RL
authors.lastname: Grubb
mesh_terms: D000368:Aged; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D015982:Bias; D001707:Biopsy, Needle; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000473:pathology* / Q000517:prevention & control / Q000601:surgery; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D016588:Anticarcinogenic Agents; D004791:Enzyme Inhibitors; D018120:Finasteride